USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Europlasma Nv

USPTO PatentsView assignee record - 8 granted patents across 18 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B05D (PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL).

8
Total patents granted
18
CPC technology areas
13.4
Avg claims per patent
+0%
5-year filing velocity

The verdict

Europlasma holds 8 US patents across 18 technology areas, rank #31,528 of 50,000 tracked assignees.

#31,528
of 50,000 US assignees by volume
Top 61%
by Innovation Score (31.9/100)
13.4
avg claims per patent
+0%
filing velocity, last 5 yrs

Portfolio overview

Europlasma Nv has been granted 8 US utility patents between 2015 and 2022, placing Europlasma Nv at rank #31,528 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.4 claims per patent with primary concentration in B05D (PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL). As a Foreign Corporation, Europlasma Nv is one of the more focused assignees in the PatentsView dataset. By volume, Europlasma sits between ESS 2 Tech, Llc (8 patents, rank #31,524) and Everpads Co., Ltd. (8 patents, rank #31,532) - the closest US assignees by grant volume. The composite Innovation Score of 31.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Europlasma Nv's 13.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Europlasma Nv against peers pursuing similar technology classes.

Who files at Europlasma's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Europlasma holds 8 patents at rank #31,528, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Europlasma

By rank, the assignees closest to #31,528 in granted patent volume.

Leaders in B05D (Processes FOR Applying Fluent Materials TO Surfaces)

Other assignees with the most granted patents in Europlasma's primary technology class.

Europlasma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

32 Top 61% higher than 39% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520172019202020212022 1
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Europlasma Nv patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 12.5%
2017 1 12.5%
2019 2 25.0%
2020 1 12.5%
2021 2 25.0%
2022 1 12.5%

Which technologies does Europlasma Nv patent most?

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#31,528

Across all tracked assignees

Innovation Score

31.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Europlasma Nv hold?
Europlasma Nv holds 8 US granted patents filed between 2015 and 2022, spanning 18 technology areas.
What is Europlasma Nv's Innovation Score?
Europlasma Nv has an Innovation Score of 31.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Europlasma Nv focus on?
Europlasma Nv's top technology area is B05D (PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL) with 5 patents. The company has filed patents in 18 CPC subclasses total.
Is Europlasma Nv's patent filing rate increasing or decreasing?
Europlasma Nv's recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Europlasma Nv's patents?
Europlasma Nv's patents average 13.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Europlasma Nv patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Europlasma's 8 grants land it in the top 61% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Europlasma ranks #31,528 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B05D - see who else leads that technology area. B05D leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.